| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/29/2003 | EP1278549A2 Cyclodextrin containing glycopeptide antibiotic compositions |
| 01/29/2003 | EP1278538A1 Cd18-binding antibodies inhibit stenosis-related disorders |
| 01/28/2003 | US6511663 Tri- and tetra-valent monospecific antigen-binding proteins |
| 01/28/2003 | US6511649 Vitronectin receptor antagonist pharmaceuticals |
| 01/28/2003 | US6511648 Vitronectin receptor antagonist pharmaceuticals |
| 01/28/2003 | CA2191950C Technetium-99m labeled peptides for imaging |
| 01/28/2003 | CA2027714C Method of measurement in biological systems |
| 01/23/2003 | WO2003006681A1 Organometallic probe |
| 01/23/2003 | WO2003006491A2 Peptide-based compounds for targeting intergin receptors |
| 01/23/2003 | WO2003006070A2 Improved chelator conjugates |
| 01/23/2003 | WO2002008293A3 Multivalent target binding protein |
| 01/23/2003 | WO2001005805A9 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/23/2003 | US20030018042 Psychological disorders; Alzheimer's disease |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017468 Nucleotide sequences which code lung preferential gene for use in the treatment and diagnosis of lung cancer |
| 01/23/2003 | US20030017456 Diagnosis and treatment and related preparations |
| 01/23/2003 | US20030017358 Metal-zirconia composite coating with resistance to molten metals and high temperature corrosive gases |
| 01/23/2003 | US20030017108 Post-labeling stabilization of radiolabeled proteins and peptides |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP1276718A2 Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 01/22/2003 | EP0901491B1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters |
| 01/21/2003 | US6509451 Cross-linked antibodies and processes for their preparation |
| 01/21/2003 | US6509003 N-alkylpiperidine derivatives labeled with radioactive iodine; use in single photon emission computed tomography (SPECT) |
| 01/21/2003 | US6509002 Carbon 13 labeled lactic acid and carrier for parenteral or oral administration; measuring radioactivity level of exhaled carbon monoxide; accurate even in light cases where subject exhibits normal blood sugar levels at time of fasting |
| 01/21/2003 | US6509001 Calcitonin receptor binding reagents |
| 01/16/2003 | WO2003004518A2 Cortistatin analogs capable of binding selectively to growth hormone secretagogue receptors |
| 01/16/2003 | WO2003003975A2 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 01/16/2003 | WO2002011715A3 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/16/2003 | WO2002004021A9 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/16/2003 | WO2002002150A8 Stable radioiodine conjugates and methods for their synthesis |
| 01/16/2003 | WO2001093913A3 T cell receptor fusions and conjugates and methods of use thereof |
| 01/16/2003 | US20030013733 Antihistamines, sleep disorders, central nervous system disorders |
| 01/16/2003 | US20030013723 Novel urokinase inhibitors |
| 01/16/2003 | US20030013674 Gene therapy; in situ supplying of genes; nucleic acid complex |
| 01/16/2003 | US20030012783 Interfere with the binding of a tumor necrosis factor receptor with its ligand; inhibiting the proliferation of tumor cells |
| 01/16/2003 | US20030012735 Methods for diagnostic imaging by regulating the administration rate of contrast agent |
| 01/16/2003 | US20030012731 Monitoring radiation and/or metabolic activity in a subject. |
| 01/16/2003 | US20030012730 E.g., radiolabelled m-iodobenzylguanidine; polydivinylbenzene-dibutyldichlorostannane product reacted with 1-(3-bomobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine; product reacted with cyanamide |
| 01/16/2003 | US20030012325 Mixture containing rare earth and the use thereof |
| 01/16/2003 | CA2449828A1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 01/15/2003 | EP1275645A1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system |
| 01/15/2003 | EP1274861A1 Compositions and methods for identifying and targeting cancer cells |
| 01/15/2003 | EP1274710A2 Novel heteroaryl-diazabicycloalkanes |
| 01/15/2003 | EP1274465A2 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
| 01/15/2003 | EP0989120B1 Reagents for assaying central local acetylcholinesterase activity |
| 01/15/2003 | EP0722442B1 Polyazacycloalkanes as dichelants |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN1390605A Medicine C-AEDP using C as carrier for target therapy of osteopath and its usage |
| 01/14/2003 | US6506364 Administering such as sodium 3-iodo-4-hydroxybenzene sulfonate which is rapidly excreted without significant tissue uptake |
| 01/14/2003 | US6506363 Radioiodinated sulfonated phenols and process therefore |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002489A2 Solid-phase electrophilic fluorination |
| 01/09/2003 | WO2003002157A1 Solid-phase nucleophilic fluorination |
| 01/09/2003 | WO2002017970A3 Metal radionuclide labelled cd-30 antibodies and uses thereof |
| 01/09/2003 | US20030009076 Device for conveying radioactive agents on angioplasty stents, respective method and kit |
| 01/09/2003 | US20030007928 Anticancer agent |
| 01/09/2003 | US20030007927 Complexing drug to leukotrienes at infection, inflammation site |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/08/2003 | EP1272665A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/08/2003 | EP1272225A2 Lipid-based systems for targeting diagnostic agents |
| 01/08/2003 | EP1272223A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 01/08/2003 | EP1272161A2 Lipid-based drug delivery systems against parasitic infections |
| 01/08/2003 | EP1272160A2 Lipid-based drug delivery systems for topical application |
| 01/08/2003 | EP1124594B1 Implant with cavities containing therapeutic agents |
| 01/08/2003 | EP1098665B1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/08/2003 | EP1098651B1 Novel urokinase inhibitors |
| 01/07/2003 | US6503477 Radiopharmaceutical compositions |
| 01/07/2003 | US6503442 Metal-zirconia composite coating with resistance to molten metals and high temperature corrosive gases |
| 01/07/2003 | US6503186 Radioactive seed with multiple markers and method for using same |
| 01/07/2003 | CA2363780C Radiolabeled compounds for thrombus imaging |
| 01/07/2003 | CA2069154C Polypeptides |
| 01/03/2003 | WO2003000736A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | WO2003000647A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents |
| 01/03/2003 | WO2003000298A1 Radioactive platinum complexes for cancer treatment |
| 01/03/2003 | WO2003000271A2 System and method for the large scale labeling of compounds with radiohalogens |
| 01/03/2003 | WO2003000113A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002007784A3 CARRIER-FREE 103Pd BRACHYTHERAPY SEEDS |
| 01/03/2003 | WO2002000193A3 Multiple stimulus reversible hydrogels |
| 01/03/2003 | WO2001092528A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |
| 01/03/2003 | CA2451239A1 Antibodies against tumor-associated antigenic taget (tat) polypeptides |
| 01/03/2003 | CA2450828A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/02/2003 | US20030004463 Delivery methods, systems and components for use with hazardous pharmaceutical substances |
| 01/02/2003 | US20030004153 Novel heteroaryl-diazabicycloalkanes |
| 01/02/2003 | US20030003521 Marker for inflammatory conditions |
| 01/02/2003 | US20030003102 Morpholino imaging and therapy |
| 01/02/2003 | US20030003097 Recombinant antibodies coexpressed with GnTIII |
| 01/02/2003 | US20030003051 Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations |
| 01/02/2003 | US20030003049 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 01/02/2003 | US20030003048 Useful in detecting and/or treating tumors or biological receptors |
| 01/02/2003 | US20030003047 Tumor radiotherapy |
| 01/02/2003 | EP1270017A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 01/02/2003 | EP1268854A1 High specificity marker detection |
| 01/02/2003 | EP1268800A2 Mucin-1 specific binding members and methods of use thereof |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268524A2 Binding peptides for carcinoembryonic antigen (cea) |
| 01/02/2003 | EP1268497A1 Ternary ligand complexes useful as radiopharmaceuticals |
| 01/02/2003 | EP1268464A1 Radioisotope-labeled complexes of glucose derivatives and kits for the preparation thereof |